Delivery Order SPE2DB20D3103-SPE2DB23FM9S8
Award Date 4/4/23
Potential Completion Date 4/5/23
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,944.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 7, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,019.04 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical supplies to the U.S. government, through its Corporate Office division. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $4,748.16 on a firm fixed-price basis. The award does not have a set-aside designation, indicating open competition. The contract is a delivery order with an ultimate completion date of July...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $3,433.30 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract has a completion date of July 3, 2024 and was awarded on July 2, 2024 without any...
- This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The $3,872.77 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 15, 2022. The contract has an ultimate completion date of November 16, 2022 and is not designated with a set-aside. This award is associated with AmerisourceBergen's $999,999,999...
- This contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $2,127.35, is a firm fixed-price delivery order with an ultimate completion date of January 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award is for the procurement of XULANE 150-35 MCG/DAY PATCH 3S medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,853.05 and has an ultimate completion date of February 19, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,389.84 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,371.22 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 11, 2023, with a completion date of May 12, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,113.43, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed-price pricing type, with a completion date of February 26, 2024. Amerisourcebergen holds a significant...